Literature DB >> 24188116

Impaired visual perception in rapid eye movement sleep behavior disorder.

Lucie Plomhause1, Kathy Dujardin1, Muriel Boucart1, Virginie Herlin1, Luc Defebvre1, Philippe Derambure1, Christelle Monaca Charley1.   

Abstract

OBJECTIVE: Patients with idiopathic REM sleep behavior disorder (iRBD) often develop synucleinopathies (Parkinson's disease [PD], in particular). Cognitive disorders affecting different domains have been reported in patients with iRBD. Dysexecutive disorders seem to predominate, but there is no consensus on the nature of visuospatial disorders in iRBD. The objective is to identify and characterize visuospatial disorders in patients with REM sleep behavior disorder (RBD - either idiopathic or associated with PD).
METHODS: Fifteen patients with iRBD, 30 patients with PD (15 of whom had RBD), and 20 healthy control subjects underwent an extensive assessment of visuospatial functions. Two computerized tasks were used: a Biederman task (to assess the 3 levels of visuoperceptive processing) and a Posner paradigm (to assess visual attention).
RESULTS: The visual priming effects classically described for the Biederman task in healthy controls were not found in iRBD patients. Patients with iRBD were no quicker in naming objects with the same general structure as previously presented objects but did have a normal priming effect for strictly identical objects. Parkinson's disease patients with RBD had poorer visuoperceptive performance levels than PD patients without RBD. There were no significant differences between the 4 groups in the Posner attentional task.
CONCLUSIONS: First, this study confirms the presence of visuoperceptive dysfunction in iRBD patients and revealed a selective defect in intermediate visuoperceptive processing (i.e., general object representation). Second, RBD in PD appeared to be associated with poorer visuoperceptive abilities. Third, this visuoperceptive dysfunction in RBD patients was not associated with impaired attention.

Entities:  

Mesh:

Year:  2013        PMID: 24188116     DOI: 10.1037/neu0000006

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  6 in total

Review 1.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

2.  Cognition and driving ability in isolated and symptomatic REM sleep behavior disorder.

Authors:  David J Sandness; Stuart J McCarter; Lucas G Dueffert; Paul W Shepard; Ashley M Enke; Julie Fields; Michelle M Mielke; Bradley F Boeve; Michael H Silber; Erik K St Louis
Journal:  Sleep       Date:  2022-04-11       Impact factor: 6.313

3.  Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease.

Authors:  Francesca Assogna; Claudio Liguori; Luca Cravello; Lucia Macchiusi; Claudia Belli; Fabio Placidi; Mariangela Pierantozzi; Alessandro Stefani; Bruno Mercuri; Francesca Izzi; Carlo Caltagirone; Nicola B Mercuri; Francesco E Pontieri; Gianfranco Spalletta; Clelia Pellicano
Journal:  J Pers Med       Date:  2021-01-16

4.  Progressive Prefrontal Cortex Dysfunction in Parkinson's Disease With Probable REM Sleep Behavior Disorder: A 3-Year Longitudinal Study.

Authors:  Xiuqin Jia; Wentao Fan; Zhijiang Wang; Yuehong Liu; Ying Li; Haibin Li; Hui Li; Ting Ma; Jing Wang; Qi Yang
Journal:  Front Aging Neurosci       Date:  2022-01-10       Impact factor: 5.750

Review 5.  A Review of Equine Sleep: Implications for Equine Welfare.

Authors:  Linda Greening; Sebastian McBride
Journal:  Front Vet Sci       Date:  2022-08-17

6.  Abnormal Striatal-Cortical Networks Contribute to the Attention/Executive Function Deficits in Idiopathic REM Sleep Behavior Disorder: A Resting State Functional MRI Study.

Authors:  Hong-Ju Zhang; Sheng-Hui Wang; Ying-Ying Bai; Jie-Wen Zhang; Shuai Chen
Journal:  Front Aging Neurosci       Date:  2021-07-01       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.